A licensed cannabis processor has filed suit against New York state to halt the January 12 rollout of a mandatory seed-to-sale tracking system. Veterans Holdings Inc., operating as Veterans Choice Creations, claims the Metrc system imposes excessive costs through required ID tags and exceeds the Office of Cannabis Management's authority. The dispute arrives amid the agency's recent enforcement setbacks, including a dropped investigation into alleged license rentals, raising fresh doubts about curbing illicit diversion.
Arguments Center on Cost and Authority
Veterans Holdings argues in its December 16 complaint that the state oversteps by mandating purchases of Metrc ID tags at 10 cents each, creating an unfair economic load. The suit highlights a shift from the prior BioTrack system, which tagged batches or lots, to Metrc's requirement for unique identifiers on individual items—a change that could multiply tag needs by hundreds or thousands. For a full indoor canopy of 10,000 square feet or outdoor expanse of 100,000 square feet, fitting one to two plants per square foot, costs could reach $2,000 or $20,000 per crop without relief.
OCM Responds with Free Tags and Defense
To address transition burdens, the Office of Cannabis Management announced on December 15 it would distribute 20 million ID tags free to licensed processors. OCM Director of Regulatory Operations Patrick McKeage affirmed on December 18 that blocking the system endangers product authenticity and consumer safety. The state must respond in court by January 7, as the agency names OCM, interim leader Susan Filburn, the Cannabis Control Board, and Metrc as defendants.
Enforcement Woes Compound the Delay Risk
New York's adult-use market began December 29, 2022, with BioTrack inventory logging planned to prevent diversion, but deadlines slipped amid retail rollout delays. The switch to Metrc followed BioTrack's August partnership announcement. Recent turmoil includes Governor Kathy Hochul's December 8 order for resignations of interim Executive Director Felicia Reid and Deputy Counsel James Rogers, who led the Trade Practices Bureau probe into Omnium Health's alleged facility rentals to unlicensed operators—a case dropped the same day without explanation.
Path Forward Hinges on Court and Stability
Filburn, now interim executive director, pledged at her first Cannabis Control Board meeting on December 18 to deliver stability and clarity while upholding public health. A successful temporary restraining order would stall a tool vital for detecting schemes like those alleged against Omnium, where investigators reviewed audits, contracts, and witness testimony. With the illicit market persistent, the outcome shapes OCM's capacity to enforce regulations two years into legalization.
